About OsoBio
OsoBio is a Healthcare company based in Albuquerque (United States) founded in 2008, and was acquired by Curia in June 2014. CMO specializing in injectables and lyophilized biological and pharmaceutical products. OsoBio offers products and services including API Manufacturing, Drug Discovery Services, and Biologics Manufacturing. Its focus areas include Biopharma Outsourcing, CDMO and Diversified. Its legal entity is Curia Global, Inc. Its competitors include Patheon, LakePharma and Maravai Life Sciences; 2 of its 3 listed competitors have raised funding.
Company details
OsoBio was founded in 2008 and is based in Albuquerque, United States. Operations focus on the pharmaceutical and biologic sectors as a contract manufacturing organization. Sterile injectable liquids, suspensions, and lyophilized products are produced for various therapeutic categories. Over 250 distinct commercial presentations have been manufactured. Services include vial filling, lyophilization, terminal sterilization, packaging, and handling of potent compounds, cytotoxics, monoclonal antibodies, suspensions, proteins, and inactivated vaccines.
- Headquarters Albuquerque, United States
- Stage Acquired
- SectorsHealthcare
- Website osobio.com
- Social LinkedIn X Facebook
- Acquired by Curia (Jun 2014)
- Legal Name Curia Global, Inc.
Products & Services of OsoBio
OsoBio offers a comprehensive portfolio of products and services, including API Manufacturing, Drug Discovery Services, and Biologics Manufacturing.
Produces active pharmaceutical ingredients for drug development
Supports early-stage drug discovery and screening processes
Handles production of biologics for clinical and commercial use
Investors in OsoBio
OsoBio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Curia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug research, development, testing, and consulting services are provided. | 1991 | curiaglobal.com | Albany, United States |
Investor details for OsoBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of OsoBio
2 dated milestones of OsoBio across 6 years, from founding to its latest funding, stage changes and deals.
- Founded OsoBio is founded.
- Exit Acquired by Curia.
Competitors of OsoBio
OsoBio has 3 listed competitors in our database, 2 of them funded. They include Patheon, LakePharma and Maravai Life Sciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| patheon.com | 1974 | Durham, United States | $141M | Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | ||
| lakepharma.com | 2009 | Belmont, United States | $30M | 212 | Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | |
| maravai.com | 2014 | San Diego, United States | 650 | Provides enabling tools and services in the life sciences research and bio-production industries |
Detailed competitors of OsoBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as OsoBio (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OsoBio
OsoBio was founded in 2008.
OsoBio is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
OsoBio was founded in 2008 and is based in Albuquerque, United States. Operations focus on the pharmaceutical and biologic sectors as a contract manufacturing organization. Sterile injectable liquids, suspensions, and lyophilized products are produced for various therapeutic categories. Over 250 distinct commercial presentations have been manufactured. Services include vial filling, lyophilization, terminal sterilization, packaging, and handling of potent compounds, cytotoxics, monoclonal antibodies, suspensions, proteins, and inactivated vaccines.
OsoBio's top competitors include Patheon, Maravai Life Sciences and LakePharma.
OsoBio offers API Manufacturing, Drug Discovery Services, and Biologics Manufacturing.
OsoBio has 1 investor. Key investors include Curia.
OsoBio operates through Curia Global, Inc..
Yes. OsoBio was acquired by Curia in June 2014.